Cadiorenal and Metabolic Diseases Research Center
心肾和代谢疾病研究中心
基本信息
- 批准号:9070043
- 负责人:
- 金额:$ 228.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-05 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AreaBasic ScienceBiochemistryBioinformaticsBiomedical ResearchCardiologyCardiovascular DiseasesCenters of Research ExcellenceCessation of lifeClinicalClinical ResearchCollaborationsComplexCore FacilityCoronary ArteriosclerosisDevelopmentDiabetes MellitusDisciplineDiseaseEducationEmerging TechnologiesEndocrinologyEnvironmentEquipmentFacultyFosteringFundingGeneticGoalsHigh PrevalenceHousingHypertensionInstitutionInterdisciplinary StudyInvestmentsKidney DiseasesLinkMedical StudentsMedical centerMentorsMetabolic DiseasesMinority-Serving InstitutionMississippiMolecular BiologyMolecular GeneticsMorbidity - disease rateNephrologyNeurosciencesObesityPathologyPharmacologyPhysiologyPopulationPopulation ResearchPostdoctoral FellowRecruitment ActivityRenal functionResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportRisk FactorsScientistServicesStrokeSystems AnalysisTrainingTraining ProgramsTranslational ResearchTranslationsUnderrepresented MinorityUnited StatesUnited States National Institutes of HealthUniversitiesWorkcareer developmentgraduate studentimprovedin vivo imaginginnovationminority investigatormortalitymultidisciplinarynext generationnovel therapeutic interventionpre-doctoralpreventprogramspublic health relevanceresearch and developmentresearch facility
项目摘要
DESCRIPTION (provided by applicant):
Cardiovascular, renal and metabolic diseases are inextricably linked and are the leading causes of mortality and morbidity in the United States, especially in Mississippi which has the highest prevalence in the nation of these diseases. These disorders usually cluster together and are highly interdependent. Obesity and associated metabolic disorders, such as diabetes, are major causes of cardiovascular and renal disease. Abnormal kidney function is an important cause as well as a consequence of hypertension, a key risk factor for cardiovascular diseases such coronary artery disease and stroke. Understanding the complex relationships among cardiovascular, renal, and metabolic disorders and developing new therapeutic approaches requires a paradigm shift in research that incorporates multidisciplinary integrated approaches, combining the efforts of basic, clinical and population scientists. A major objective of this proposal is to develop an internationally recognized Cardiorenal and Metabolic Diseases Research Center (CMDRC) that brings together a multidisciplinary group of basic, clinical and population scientists working on a common synergistic theme, and to facilitate their collaborations. The specific aims are: 1) To develop infrastructure and core facilities that foster
excellence in basic, clinical, and population research in cardiorenal and metabolic diseases and increase competitiveness of junior investigators for independent funding from NIH and other national biomedical research programs.; 2) To develop mentoring and education programs and research support for promising junior investigators so that they can become productive, independent investigators who can successfully compete for NIH funding; 3) To achieve the specific aims of the research projects described by the junior investigators in this proposal, and to foster their career development; 4) To develop a pipeline of diverse predoctoral graduate students, medical students and postdoctoral fellows trained in cutting edge cardiorenal and metabolic diseases research so they become the next generation of researchers in this field; major emphasis will be placed on recruiting and mentoring underrepresented minority investigators through partnerships with local minority institutions; 5) To enhance collaborations and interactions among established investigators from multiple disciplines in cardiorenal and metabolic diseases at UMMC, as well as with external partners; 6) To strengthen cardiorenal and metabolic disease research at UMMC by recruiting new faculty with expertise in clinical and translational research and in emerging technologies, such as in vivo imaging, molecular genetics, bioinformatics, and systems analysis.
描述(由申请人提供):
心血管,肾脏和代谢疾病是密不可分的,是美国死亡率和发病率的主要原因,尤其是在密西西比州,在这些疾病中的患病率最高。这些疾病通常聚集在一起,并且高度相互依存。肥胖和相关的代谢疾病(例如糖尿病)是心血管和肾脏疾病的主要原因。肾脏功能异常是高血压的重要原因,也是心血管疾病等冠状动脉疾病和中风的关键危险因素。了解心血管,肾脏和代谢疾病之间的复杂关系并开发新的治疗方法需要研究范式的范式转变,并结合了基本,临床和人群科学家的努力,并结合了多学科综合方法。该提案的一个主要目的是开发一个国际认可的心脏和代谢性疾病研究中心(CMDRC),该疾病汇集了一个多学科的基本,临床和人群科学家,致力于共同的协同主题,并促进他们的合作。具体目的是:1)开发促进基础设施和核心设施
在心脏和代谢疾病方面的基本,临床和人群研究方面的卓越表现,并提高了NIH和其他国家生物医学研究计划的初级研究人员的竞争力。 2)为有前途的初级调查人员开发指导和教育计划和研究支持,以便他们可以成为可以成功竞争NIH资金的富有成效的独立研究人员; 3)实现初级研究人员在本提案中描述的研究项目的具体目标,并促进其职业发展; 4)开发了一条多种多样的研究生,医学生和在尖端心脏和代谢疾病研究的培训的博士后研究员的管道,以便他们成为该领域的下一代研究人员;主要重点将通过与当地少数族裔机构的合作伙伴关系来招募和指导代表性不足的少数群体调查员; 5)增强来自UMMC的心脏和代谢疾病多个学科的既定研究人员之间的合作和互动,以及与外部伴侣的合作; 6)通过招募具有临床和转化研究和新兴技术方面的专业知识的新教师(例如在体内成像,分子遗传学,生物信息学和系统分析)中,可以加强UMMC的心脏和代谢疾病研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John E Hall其他文献
Chapter 44 – Obesity and Hypertension: Impact on Cardiovascular and Renal Systems
第 44 章 – 肥胖和高血压:对心血管和肾脏系统的影响
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
John E Hall;Daniel W. Jones;J. Kuo;A. Silva;Jiankang Liu;Lakshmi S. Tallam - 通讯作者:
Lakshmi S. Tallam
John E Hall的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John E Hall', 18)}}的其他基金
Cardiorenal and Metabolic Diseases Research Center
心肾与代谢疾病研究中心
- 批准号:
10630577 - 财政年份:2023
- 资助金额:
$ 228.53万 - 项目类别:
Cardiorenal and Metabolic Diseases Research Center
心肾与代谢疾病研究中心
- 批准号:
10887793 - 财政年份:2023
- 资助金额:
$ 228.53万 - 项目类别:
Core A - Administrative, Mentoring and Education Core
核心 A - 行政、指导和教育核心
- 批准号:
10403629 - 财政年份:2013
- 资助金额:
$ 228.53万 - 项目类别:
Cardiorenal and Metabolic Diseases Research Center
心肾与代谢疾病研究中心
- 批准号:
9920739 - 财政年份:2013
- 资助金额:
$ 228.53万 - 项目类别:
Core A - Administrative, Mentoring and Education Core
核心 A - 行政、指导和教育核心
- 批准号:
10159918 - 财政年份:2013
- 资助金额:
$ 228.53万 - 项目类别:
Cadiorenal and Metabolic Diseases Research Center
心肾和代谢疾病研究中心
- 批准号:
8730199 - 财政年份:2013
- 资助金额:
$ 228.53万 - 项目类别:
Cadiorenal and Metabolic Diseases Research Center
心肾和代谢疾病研究中心
- 批准号:
8848396 - 财政年份:2013
- 资助金额:
$ 228.53万 - 项目类别:
相似国自然基金
磁性功能微球在核酸快速提取及检测中的基础科学问题探究
- 批准号:52373131
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
极端高温环境流动沸腾技术的基础科学问题及关键材料研究
- 批准号:52333015
- 批准年份:2023
- 资助金额:230 万元
- 项目类别:重点项目
先进航空发动机中超临界态煤油燃烧过程中的基础科学问题研究
- 批准号:52336006
- 批准年份:2023
- 资助金额:230 万元
- 项目类别:重点项目
企业基础科学研究的动因、机制与经济效果研究
- 批准号:72302229
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
耐高温高电压SiC功率器件灌封材料的多性能协同中的基础科学问题研究
- 批准号:52272001
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
2023 Muscle: Excitation-Contraction Coupling Gordon Research Conference and Gordon Research Seminar
2023肌肉:兴奋-收缩耦合戈登研究会议暨戈登研究研讨会
- 批准号:
10606049 - 财政年份:2023
- 资助金额:
$ 228.53万 - 项目类别:
2021 Mitochondria in Health and Disease Gordon Research Conference
2021 年线粒体健康与疾病戈登研究会议
- 批准号:
10236763 - 财政年份:2023
- 资助金额:
$ 228.53万 - 项目类别:
Transcription and Replication of Oncogenic Viruses in Hypoxia
缺氧条件下致癌病毒的转录和复制
- 批准号:
10714172 - 财政年份:2023
- 资助金额:
$ 228.53万 - 项目类别:
ASMB 2023: Tissue, Matrix, and Pathobiology
ASMB 2023:组织、基质和病理生物学
- 批准号:
10752769 - 财政年份:2023
- 资助金额:
$ 228.53万 - 项目类别: